help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tatsuno, I.
Right arrow Articles by Arimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tatsuno, I.
Right arrow Articles by Arimura, A.

Endocrinology, Vol 131, 73-81, Copyright © 1992 by Endocrine Society


ARTICLES

Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons

I Tatsuno, T Yada, S Vigh, H Hidaka and A Arimura
US-Japan Biomedical Research Laboratories, Tulane University Hebert Center, Belle Chasse, Louisiana 70037.

Recently, pituitary adenylate cyclase activating polypeptide (PACAP) was isolated from ovine hypothalamus and it was shown to stimulate adenylate cyclase in rat pituitary cells, neurons, and astrocytes. PACAP exhibits a 68% amino acid sequence homology with vasoactive intestinal peptide (VIP); however, it is 1000 times more potent than VIP in stimulating adenylate cyclase. In view of the wide distribution of PACAP and its receptor in the central nervous system, PACAP is likely to act as a neurotransmitter or neuromodulator as well. In the present study, we investigated the effects of PACAP38 on cytosolic-free calcium concentrations ([Ca2+]i) and compared these effects with those of VIP in cultured rat hippocampal neurons. Calcium concentrations, at the single cell level, were measured using fura-2, a calcium sensitive fluorescent dye, and fura-2-loaded neurons were continuously superfused at 37 C and viewed under an inverted microscope. Images of these neurons were recorded at 10-sec intervals by a video camera equipped with an Argus-50/CA system which controls the image acquisition and display. [Ca2+]i was quantitated from the intensities of fluorescence of the cells at two excitation wavelengths of 340 and 380 nm. The ratio of the intensities of emitted fluorescence (340/380 nm) was calibrated to determine [Ca2+]i. PACAP38 (0.1 nM) increased [Ca2+]i in some hippocampal neurons. As the concentration of peptide was increased from 0.1 to 10 nM, the accumulated number of hippocampal neurons responding to PACAP38 progressively increased and reached a plateau at 10 nM. Total neurons (33.0 +/- 5.3%, n = 4; 502 neurons) were found to respond to 100 nM PACAP38. The half-maximal concentration (ED50) of PACAP38 was 2.60 +/- 0.77 nM. Typically, 60-90 sec after the addition of PACAP38 (10 nM), [Ca2+]i increased from basal levels of 50-100 to 150-300 nM. VIP also increased [Ca2+]i, but required 1 microM or higher concentration for a considerable number of cells to respond. The number of hippocampal neurons responding to VIP at 1 microM was 28.9 +/- 9.8% (n = 4; 442 cells) which was comparable to the population of neurons responding to 10 nM PACAP38. The ED50 for VIP was 0.68 +/- 0.38 microM which was approximately 260 times higher than the ED50 for PACAP38. Neither 1-10 microM nitrendipine, a L-type voltage-dependent Ca2+ channel blocker, or 1 microM omega-conotoxin GVIA, a N-type voltage- dependent Ca2+ channel blocker, altered the PACAP-induced Ca2+ increment. Removal of Ca2+ from the superfusion media did not influence the PACAP38-induced increase of [Ca2+]i.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Bhattacharya, S. S. Lakhman, and S. Singh
Modulation of L-type Calcium Channels in Drosophila via a Pituitary Adenylyl Cyclase-activating Polypeptide (PACAP)-mediated Pathway
J. Biol. Chem., September 3, 2004; 279(36): 37291 - 37297.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Fizanne, D. Sigaudo-Roussel, J. L. Saumet, and B. Fromy
Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents
J. Physiol., January 15, 2004; 554(2): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Payet, L. Bilodeau, L. Breault, A. Fournier, L. Yon, H. Vaudry, and N. Gallo-Payet
PAC1 Receptor Activation by PACAP-38 Mediates Ca2+ Release from a cAMP-dependent Pool in Human Fetal Adrenal Gland Chromaffin Cells
J. Biol. Chem., January 10, 2003; 278(3): 1663 - 1670.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. S. Lee, R. Rajagopal, A. H. Kim, P. C. Chang, and M. V. Chao
Activation of Trk Neurotrophin Receptor Signaling by Pituitary Adenylate Cyclase-activating Polypeptides
J. Biol. Chem., March 8, 2002; 277(11): 9096 - 9102.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Furuya, R. J. Milchak, K. M. Schegg, J. Zhang, S. S. Tobe, G. M. Coast, and D. A. Schooley
Cockroach diuretic hormones: Characterization of a calcitonin-like peptide in insects
PNAS, June 6, 2000; 97(12): 6469 - 6474.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Tanaka, I. Tatsuno, D. Uchida, I. Moroo, H. Morio, S. Nakamura, Y. Noguchi, T. Yasuda, M. Kitagawa, Y. Saito, et al.
Geranylgeranyl-Pyrophosphate, an Isoprenoid of Mevalonate Cascade, Is a Critical Compound for Rat Primary Cultured Cortical Neurons to Protect the Cell Death Induced by 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibition
J. Neurosci., April 15, 2000; 20(8): 2852 - 2859.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Braas and V. May
Pituitary Adenylate Cyclase-activating Polypeptides Directly Stimulate Sympathetic Neuron Neuropeptide Y Release through PAC1 Receptor Isoform Activation of Specific Intracellular Signaling Pathways
J. Biol. Chem., September 24, 1999; 274(39): 27702 - 27710.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. El-Gehani, M. Tena-Sempere, and I. Huhtaniemi
Vasoactive Intestinal Peptide Is an Important Endocrine Regulatory Factor of Fetal Rat Testicular Steroidogenesis
Endocrinology, April 1, 1998; 139(4): 1474 - 1480.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Brandenburg, V. May, and K. M. Braas
Identification of Endogenous Sympathetic Neuron Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP): Depolarization Regulates Production and Secretion through Induction of Multiple Propeptide Transcripts
J. Neurosci., June 1, 1997; 17(11): 4045 - 4055.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
W Li, T Tully, and D Kalderon
Effects of a conditional Drosophila PKA mutant on olfactory learning and memory.
Learn. Mem., January 1, 1996; 2(6): 320 - 333.
[Abstract] [PDF]


Home page
ScienceHome page
E Kandel and T Abel
Neuropeptides, adenylyl cyclase, and memory storage
Science, May 12, 1995; 268(5212): 825 - 826.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society